Tri-b-GalNAc-gly-C6-DBCO
Ref. 3D-MT184245
| 1mg | 465,00 € | ||
| 5mg | 1.392,00 € |
Información del producto
- Tris-β-GalNAc-Gly-DBCOTrebler GalNAc DBCODBCO-Gly-tris-beta-GalNAc
Tri-b-GalNAc-Gly-C6-DBCO is used for targeted siRNA therapies for liver diseases. This synthetic molecule boasts three terminal beta-N-acetylgalactosamine (GalNAc) sugars (tri-antennary GalNAc) enabling high-affinity binding to the asialoglycoprotein receptor (ASGPR) on hepatocyte surfaces. This specific recognition promotes efficient cellular uptake of these cluster conjugates via ASGPR-mediated endocytosis. Crucially, the presence of a C6 spacer and a dibenzoeylcyclooctynone (DBCO) group allows for the attachment of siRNA molecules through bioorthogonal click chemistry. This versatile approach facilitates the development of targeted siRNA conjugates that can be delivered specifically to hepatocytes for RNA interference (RNAi) applications in the liver.
Propiedades químicas
Consulta técnica sobre: 3D-MT184245 Tri-b-GalNAc-gly-C6-DBCO
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
